Keyphrases
Testicular Cancer
82%
Germ Cell Tumor
59%
Cisplatin
55%
Chemotherapy
51%
Cancer Patients
49%
Bleomycin
43%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
41%
Etoposide
34%
Testicular Cancer Survivors
34%
Overall Survival
33%
Testicular Germ Cell Tumor
28%
Docetaxel
24%
Leydig Cell Dysfunction
19%
Positron Emission Tomography
19%
Primary Tumor Site
19%
Progression-free Survival
18%
In Cancer
18%
National Cohort Study
17%
Small Cell Lung Cancer
17%
Phase II Study
17%
Resistance Training
17%
Stage I Seminoma
17%
Cancer of Unknown Primary
17%
Tumor
16%
Metastasis
16%
Medicine and Dentistry
Testis Cancer
100%
Germ Cell Cancer
74%
Cisplatin
44%
Malignant Neoplasm
40%
Metastatic Carcinoma
40%
Bleomycin
38%
Etoposide
37%
Seminoma
33%
Neoplasm
31%
Overall Survival
25%
Diseases
24%
Primary Tumor
23%
Interstitial Cell
19%
positron emission tomographic scan
19%
Castration Resistant Prostate Cancer
17%
Small Cell Lung Cancer
17%
Resistance Training
17%
Biopsy Technique
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
61%
Testis Cancer
53%
Cisplatin
51%
Castration Resistant Prostate Cancer
46%
Malignant Neoplasm
42%
Overall Survival
37%
Germ Cell Cancer
33%
Docetaxel
31%
Etoposide
27%
Neoplasm
26%
Bleomycin
26%
Progression Free Survival
23%
Placebo
19%
Diseases
17%
Seminoma
15%
